论文部分内容阅读
CD8+ T lymphocytes (CTL) can exert potent in vivo cytotoxicity against autologous melanoma cells.However, T-cell activity is impaired when poorly immunogenic tumor phenotypes evolve in the course of disease progression.Here we studied the immunogenicity of multiple consecutive metastases obtained in stage Ⅳ disease from three melanoma patients.